BioCryst Pharmaceuticals Inc (BCRX)
7.49
+0.19
(+2.60%)
USD |
NASDAQ |
Nov 21, 16:00
7.485
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals Total Assets (Quarterly): 491.25M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 491.25M |
| June 30, 2024 | 472.42M |
| March 31, 2024 | 467.89M |
| December 31, 2023 | 516.96M |
| September 30, 2023 | 522.92M |
| June 30, 2023 | 529.88M |
| March 31, 2023 | 509.74M |
| December 31, 2022 | 550.00M |
| September 30, 2022 | 558.59M |
| June 30, 2022 | 510.54M |
| March 31, 2022 | 527.72M |
| December 31, 2021 | 588.15M |
| September 30, 2021 | 265.76M |
| June 30, 2021 | 277.28M |
| March 31, 2021 | 284.43M |
| December 31, 2020 | 334.72M |
| September 30, 2020 | 176.23M |
| June 30, 2020 | 214.71M |
| March 31, 2020 | 136.59M |
| December 31, 2019 | 175.28M |
| September 30, 2019 | 90.50M |
| June 30, 2019 | 116.34M |
| March 31, 2019 | 142.34M |
| December 31, 2018 | 146.84M |
| September 30, 2018 | 168.31M |
| Date | Value |
|---|---|
| June 30, 2018 | 136.64M |
| March 31, 2018 | 155.37M |
| December 31, 2017 | 178.26M |
| September 30, 2017 | 191.49M |
| June 30, 2017 | 113.51M |
| March 31, 2017 | 129.51M |
| December 31, 2016 | 89.85M |
| September 30, 2016 | 91.50M |
| June 30, 2016 | 82.22M |
| March 31, 2016 | 102.88M |
| December 31, 2015 | 122.36M |
| September 30, 2015 | 138.96M |
| June 30, 2015 | 150.18M |
| March 31, 2015 | 129.87M |
| December 31, 2014 | 136.87M |
| September 30, 2014 | 137.12M |
| June 30, 2014 | 141.98M |
| March 31, 2014 | 43.39M |
| December 31, 2013 | 48.87M |
| September 30, 2013 | 53.20M |
| June 30, 2013 | 39.92M |
| March 31, 2013 | 46.90M |
| December 31, 2012 | 57.44M |
| September 30, 2012 | 64.09M |
| June 30, 2012 | 76.24M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
136.59M
Minimum
Mar 2020
588.15M
Maximum
Dec 2021
405.55M
Average
481.84M
Median
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 13.59M |
| Perspective Therapeutics Inc | 391.15M |
| Protalix BioTherapeutics Inc | 61.56M |
| Electromed Inc | 48.92M |
| Armata Pharmaceuticals Inc | 98.24M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 959.82M |
| Shareholders Equity (Quarterly) | -468.56M |
| Debt to Equity Ratio | -1.699 |
| Current Ratio | 2.781 |
| Net Debt Paydown Yield | 0.29% |